2 min read
High-dose influenza vaccination remains a cost-effective investment for older adults in the Netherlands
Updated health-economic evidence, drawing on data from more than 85 million individuals, confirms that switching from standard-dose to high-dose influenza vaccination would prevent thousands of hospitalisations each year, at a cost well within...
Read More